Systematic review of 17 studies with pooled analyses in hospitalised adults with AmpC-producing Enterobacterales infections: carbapenems vs non-carbapenems showed no significant difference in 30-day mortality (OR 1.29, P=0.16) but more adverse drug reactions (OR 4.32).
Meta-analysisn = 17 studies
Saleh et al. Comparative efficacy and safety of carbapenems vs noncarbapenem antibiotics in AmpC-producing Enterobacterales infections: A systematic review and meta-analysis